Subscribe to RSS
DOI: 10.1055/a-2764-2296
Postpartum Hemorrhagic Morbidities with Livebirth versus Stillbirth
Authors
Abstract
Objective
ACOG publications on stillbirth or postpartum hemorrhage (PPH) do not consider stillbirth as a risk factor for postpartum hemorrhagic morbidity. This study aimed to ascertain the likelihood of composite maternal hemorrhagic outcome (CMHO) among individuals who delivered vaginally with livebirth versus a stillbirth.
Study Design
This was a retrospective cohort study of all parturients greater than 20 weeks gestation who delivered vaginally at a single level IV site within 24 months. Demographic differences and baseline PPH risks were analyzed. CMHO included any of the following: estimated blood loss ≥1,000 mL, use of uterotonics (beyond prophylactic oxytocin), Bakri balloon, surgical management of PPH, blood transfusion, hysterectomy, venous thromboembolism (VTE), admission to the intensive care unit (ICU), or maternal death. Statistical analysis included chi-squared, Kruskal-Wallis, and Poisson regression with robust error variance for risk ratios, adjusting for gestational age (GA), bleeding on admission, chorioamnionitis, and prior uterine surgery.
Results
Of 8,623 consecutive vaginal births ≥20 weeks gestation, 89 (1.9%) were stillbirths. Maternal age, marital status, GA at delivery, and PPH risk stratification at admission differed significantly. Bleeding at admission (p < 0.001), prior uterine surgery (p < 0.001), magnesium sulfate use (p = 0.006), chorioamnionitis (p < 0.001), platelet count <100 (p = 0.001), platelet count <50 (p < 0.001), and retained products of conception (p < 0.001) were different in the two groups. CMHO was significantly higher with a stillbirth delivery (32.6 vs. 16.8%; aRR: 1.56, 95% CI: 1.01–2.46). After adjustment, the components of the CMHO that differed significantly were estimated blood loss ≥1,000 mL and ICU admission. Tamponade, surgical intervention, VTE, hysterectomy, and maternal death did not differ between the two groups.
Conclusion
Pregnancies with stillbirth, compared with livebirth, had an increased risk of hemorrhagic related morbidity. In addition to being useful in shared decision-making, our results can be nidus for intervention trials to decrease the hemorrhagic morbidity associated with stillbirth.
Key Points
-
The risk of CMHO was significantly higher in the stillbirth group even after adjustment for potential confounders (32.6% vs. 16.8%).
-
Stillbirth was associated with a significantly higher risk of blood loss of ≥1,000 mL.
-
Stillbirth was also associated with higher likelihood of uterotonic use, transfusion, and admission to ICU.
Keywords
blood loss - hysterectomy - intensive care unit - maternal mortality - tamponade - transfusion - uterotonic usePublication History
Received: 14 March 2025
Accepted: 03 December 2025
Accepted Manuscript online:
05 December 2025
Article published online:
15 December 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 American College of Obstetricians and Gynecologists. Society for Maternal-Fetal Medicine in collaboration with; Metz TD, Berry RS, Fretts RC, Reddy UM, Turrentine MA. Obstetric Care Consensus #10: Management of Stillbirth: (Replaces Practice Bulletin Number 102, March 2009). Am J Obstet Gynecol 2020; 222: B2-B20
- 2 MacDorman MF, Gregory EC. Fetal and perinatal mortality: United States, 2013. Natl Vital Stat Rep 2015; 64 (08) 1-24
- 3 Burden C, Merriel A, Bakhbakhi D, Heazell A, Siassakos D. Care of late intrauterine fetal death and stillbirth. BJOG 2024; 00: 1-41
- 4 Leduc L. No. 394-stillbirth investigation. J Obstet Gynaecol Can 2020; 42 (01) 92-99
- 5 Committee on Practice Bulletins-Obstetrics. Practice BulletinNo.183: postpartum hemorrhage. Obstet Gynecol 2017; 130 (04) e168-e186
- 6 Ghose I, Wiley RL, Ciomperlik HN. et al. Association of adverse outcomes with three-tiered risk assessment tool for obstetrical hemorrhage. Am J Obstet Gynecol MFM 2023; 5 (10) 101106
- 7 Nyarko SH, Greenberg LT, Phibbs CS. et al. Association between stillbirth and severe maternal morbidity. Am J Obstet Gynecol 2024; 230 (03) 364.e1-364.e14
- 8 Wall-Wieler E, Carmichael SL, Gibbs RS. et al. Severe maternal morbidity among stillbirth and live birth deliveries in California. Obstet Gynecol 2019; 134 (02) 310-317
- 9 Lewkowitz AK, Rosenbloom JI, López JD. et al. Association between stillbirth at 23 weeks of gestation or greater and severe maternal morbidity. Obstet Gynecol 2019; 134 (05) 964-973
- 10 Boulanger V, MacLaurin A, Quach C. Barriers and facilitators for using administrative data for surveillance purpose: a narrative overview. J Hosp Infect 2025; 155: 25-36
- 11 Gold KJ, Mozurkewich EL, Puder KS, Treadwell MC. Maternal complications associated with stillbirth delivery: a cross-sectional analysis. J Obstet Gynaecol 2016; 36 (02) 208-212
- 12 Negesa Beyene B, Jara Boneya D, Gelchu Adola S. et al. Factors associated with postpartum hemorrhage in selected Southern Oromia hospitals, Ethiopia, 2021: an unmatched case-control study. Front Glob Womens Health 2024; 5: 1332719
- 13 Gregory ECW, Valenzuela CP, Martin JA. Fetal Mortality in the United States: Final 2020–2021 and 2021–Provisional 2022. NVSS Vital Statistics Rapid Release. Report No. 32. November 2023. Centers for Disease Control and Prevention (CDC). Accessed June 6, 2025 at: https://www.cdc.gov/nchs/data/vsrr/vsrr032.pdf
- 14 Maslow AD, Breen TW, Sarna MC, Soni AK, Watkins J, Oriol NE. Prevalence of coagulation abnormalities associated with intrauterine fetal death. Can J Anaesth 1996; 43 (12) 1237-1243
- 15 Goldenberg RL, McClure EM, Saleem S, Reddy UM. Infection-related stillbirths. Lancet 2010; 375 (9724) 1482-1490
- 16 Committee Opinion No. 712: intrapartum management of intraamniotic infection. Obstet Gynecol 2017; 130 (02) e95-e101
- 17 Rouse DJ, Landon M, Leveno KJ. et al; National Institute of Child Health And Human Development, Maternal-Fetal Medicine Units Network. The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol 2004; 191 (01) 211-216
- 18 Dombrowski MP, Bottoms SF, Saleh AA, Hurd WW, Romero R. Third stage of labor: analysis of duration and clinical practice. Am J Obstet Gynecol 1995; 172 (4 Pt 1): 1279-1284
